Jump Financial LLC Raises Position in OraSure Technologies, Inc. (NASDAQ:OSUR)

Posted by Defense World Staff on Aug 8th, 2023

Jump Financial LLC lifted its stake in OraSure Technologies, Inc. (NASDAQ:OSUR – Free Report) by 27.3% in the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 67,600 shares of the medical instruments supplier’s stock after purchasing an additional 14,500 shares during the quarter. Jump Financial LLC owned about 0.09% of OraSure Technologies worth $409,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. FMR LLC increased its position in OraSure Technologies by 249.6% during the second quarter. FMR LLC now owns 10,687 shares of the medical instruments supplier’s stock valued at $29,000 after acquiring an additional 7,630 shares during the last quarter. 1832 Asset Management L.P. bought a new stake in OraSure Technologies in the first quarter worth about $40,000. UBS Group AG lifted its stake in OraSure Technologies by 82.3% in the third quarter. UBS Group AG now owns 11,217 shares of the medical instruments supplier’s stock worth $42,000 after purchasing an additional 5,064 shares during the last quarter. Archon Capital Management LLC purchased a new position in shares of OraSure Technologies during the fourth quarter valued at approximately $48,000. Finally, Jane Street Group LLC bought a new position in shares of OraSure Technologies during the third quarter valued at approximately $49,000. Hedge funds and other institutional investors own 85.06% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the company. Stephens dropped their price objective on OraSure Technologies from $6.50 to $5.00 in a report on Monday, July 17th. TheStreet cut shares of OraSure Technologies from a “c” rating to a “d+” rating in a report on Friday. Finally, StockNews.com cut shares of OraSure Technologies from a “buy” rating to a “hold” rating in a research report on Friday, July 7th.

Check Out Our Latest Research Report on OSUR

OraSure Technologies Trading Up 7.7 %

OSUR opened at $6.40 on Tuesday. The company has a market capitalization of $468.86 million, a price-to-earnings ratio of 11.03 and a beta of 0.08. OraSure Technologies, Inc. has a 12-month low of $3.13 and a 12-month high of $7.82. The business’s fifty day simple moving average is $4.99 and its 200-day simple moving average is $5.69.

OraSure Technologies (NASDAQ:OSUR – Get Free Report) last released its quarterly earnings data on Wednesday, May 10th. The medical instruments supplier reported $0.37 earnings per share for the quarter, topping analysts’ consensus estimates of $0.16 by $0.21. The company had revenue of $154.96 million during the quarter, compared to analyst estimates of $127.14 million. OraSure Technologies had a net margin of 9.01% and a return on equity of 11.58%. On average, equities research analysts predict that OraSure Technologies, Inc. will post 0.19 EPS for the current year.

OraSure Technologies Profile

(Free Report)

OraSure Technologies, Inc, together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions.